SI1620085T1 - Uporaba derivatov fenoksiocetne kisline za zdravljenje hiperaktivnega sečnega mehurja - Google Patents

Uporaba derivatov fenoksiocetne kisline za zdravljenje hiperaktivnega sečnega mehurja

Info

Publication number
SI1620085T1
SI1620085T1 SI200430884T SI200430884T SI1620085T1 SI 1620085 T1 SI1620085 T1 SI 1620085T1 SI 200430884 T SI200430884 T SI 200430884T SI 200430884 T SI200430884 T SI 200430884T SI 1620085 T1 SI1620085 T1 SI 1620085T1
Authority
SI
Slovenia
Prior art keywords
treatment
acid derivatives
urinary bladder
phenoxyacetic acid
hyperactive
Prior art date
Application number
SI200430884T
Other languages
English (en)
Slovenian (sl)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1620085(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of SI1620085T1 publication Critical patent/SI1620085T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200430884T 2003-05-05 2004-03-24 Uporaba derivatov fenoksiocetne kisline za zdravljenje hiperaktivnega sečnega mehurja SI1620085T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
EP04722967A EP1620085B1 (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder
PCT/JP2004/004048 WO2004098586A1 (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Publications (1)

Publication Number Publication Date
SI1620085T1 true SI1620085T1 (sl) 2008-12-31

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430884T SI1620085T1 (sl) 2003-05-05 2004-03-24 Uporaba derivatov fenoksiocetne kisline za zdravljenje hiperaktivnega sečnega mehurja

Country Status (26)

Country Link
US (1) US20040229947A1 (https=)
EP (1) EP1620085B1 (https=)
JP (1) JP4602969B2 (https=)
KR (1) KR101052804B1 (https=)
AR (1) AR044169A1 (https=)
AT (1) ATE401878T1 (https=)
AU (1) AU2004236596B2 (https=)
BR (1) BRPI0409980A (https=)
CA (1) CA2524023C (https=)
CL (1) CL2004000952A1 (https=)
CY (1) CY1108425T1 (https=)
DE (1) DE602004015272D1 (https=)
DK (1) DK1620085T3 (https=)
ES (1) ES2309513T3 (https=)
IL (1) IL171713A (https=)
MX (1) MXPA05011862A (https=)
MY (1) MY141756A (https=)
NZ (1) NZ543347A (https=)
PE (1) PE20050524A1 (https=)
PL (1) PL1620085T3 (https=)
PT (1) PT1620085E (https=)
RU (1) RU2342133C2 (https=)
SI (1) SI1620085T1 (https=)
TW (1) TWI351279B (https=)
UY (1) UY28306A1 (https=)
WO (1) WO2004098586A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
CA2605298A1 (en) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
US7763654B2 (en) * 2005-04-26 2010-07-27 Kissei Pharmaceutical Co., Ltd. Crystal polymorph of hydroxynorephedrin derivative hydrochloride
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
EP4410295A3 (en) 2017-06-06 2024-10-16 Urovant Sciences GmbH Use of vibegron to treat overactive bladder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
US6410484B1 (en) * 1999-11-01 2002-06-25 Sumitomo Chemical Company, Limited 6-Hydroxy-5,6-dihydrouracil compound and herbicidal composition containing thereof
MXPA04002449A (es) * 2001-09-13 2004-07-23 Kissei Pharmaceutical Cristales de derivado de hidroxinorefedrina.

Also Published As

Publication number Publication date
ES2309513T3 (es) 2008-12-16
EP1620085A1 (en) 2006-02-01
CA2524023C (en) 2011-11-22
EP1620085B1 (en) 2008-07-23
CY1108425T1 (el) 2014-04-09
JP4602969B2 (ja) 2010-12-22
KR101052804B1 (ko) 2011-07-29
IL171713A (en) 2011-12-29
JP2006525318A (ja) 2006-11-09
DK1620085T3 (da) 2008-11-24
CA2524023A1 (en) 2004-11-18
US20040229947A1 (en) 2004-11-18
PE20050524A1 (es) 2005-07-07
CL2004000952A1 (es) 2005-03-04
WO2004098586A1 (en) 2004-11-18
PT1620085E (pt) 2008-08-07
ATE401878T1 (de) 2008-08-15
AU2004236596B2 (en) 2010-03-11
AR044169A1 (es) 2005-08-24
RU2005137701A (ru) 2006-06-10
UY28306A1 (es) 2004-12-31
KR20060009886A (ko) 2006-02-01
MXPA05011862A (es) 2006-02-17
MY141756A (en) 2010-06-30
NZ543347A (en) 2008-05-30
RU2342133C2 (ru) 2008-12-27
DE602004015272D1 (de) 2008-09-04
TW200509902A (en) 2005-03-16
PL1620085T3 (pl) 2009-01-30
BRPI0409980A (pt) 2006-05-09
TWI351279B (en) 2011-11-01
AU2004236596A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
DK1660431T3 (da) Phenoxyeddikesyrederivater
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DK2279767T3 (da) Urinvejskateter
CY2016046I2 (el) Κινοζολινονες ως αναστολεις της ανθρωπινης 3-κινασης δελτα της φωσφατιδυλοσιτολης
DE502004008604D1 (de) Pyrrolopyridin-substitutierte benzol-derivate zur behandlung kardiovaskulärer erkrankungen
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
DK1849773T3 (da) Piperazinderivater til behandlingen af urininkontinens og smerte
PT1506781E (pt) Composicao para tratamento vaginal
DK1692242T3 (da) Viskoelastisk syre
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ZA200707560B (en) 5-phenyl-pentanoc acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
DE602004011548D1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
DK1650186T3 (da) Nye dicarboxylsyrederivater
EP1744740A4 (en) PHENOXYALKYCARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
HRP20150320T1 (xx) Formulacije i metode za lijeäśenje amiloidoze
ATE439347T1 (de) 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
PL378212A1 (pl) Inhibitory 3-hydroksylazy kynureninowej do leczenia cukrzycy
SI1620085T1 (sl) Uporaba derivatov fenoksiocetne kisline za zdravljenje hiperaktivnega sečnega mehurja
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
ATE448228T1 (de) Pyrrolopyrimidinderivate zur behandlung proliferativer krankheiten
ZA200605302B (en) Use of pentadienoic acid derivatives for the treatment of hyperuricemia